Freenome, Inc. (FRNM): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$864.7K

Year ended 2025-12-31

-$907.0K

Trailing 12 months to 2026-06-30

Period ended	Operating Cash Flow	Change YoY	Source filing
2025-12-31	-$864.7K	n/a	2026-03-12, From 2025-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Cash Flow	Change YoY
Freenome, Inc. (FRNM)	2025-12-31	-$864.7K	n/a
Biodesix Inc (BDSX)	2025-12-31	-$23.27M	n/m
Sera Prognostics, Inc. (SERA)	2025-12-31	-$25.62M	n/m
Exagen Inc. (XGN)	2025-12-31	-$13.62M	n/m
American Shared Hospital Services (AMS)	2025-12-31	$3.10M	n/m
CapForce Inc. (CFOR)	2025-12-31	-$1.18M	n/m
Personalis, Inc. (PSNL)	2025-12-31	-$74.95M	n/m
CareDx, Inc. (CDNA)	2025-12-31	$42.03M	+10.5%
Celcuity Inc. (CELC)	2025-12-31	-$153.28M	n/m

Compare FRNM, BDSX, SERA, XGN side by side · Screen every company in Services-Medical Laboratories ↗